Pharming Group N.V. (PHAR) - Earnings growth in current year
Is it worth investing in a business that attracts top biologists to combat rare pathologies? The year-over-year EPS growth rates provide the answer, and the value of 783.20 shows the current magnitude. Exclusive patents and strict FDA and EMA oversight serve as a defense for Pharming Group N.V. (PHAR). Meanwhile, Pharming Group N.V. (PHAR) is successfully diversifying its portfolio by launching a new drug for the immune system.
Financial and market metric breakdowns for Pharming Group (PHAR)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Aggregate Debt to Equity Pharming Group N.V.|PHAR - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Pharming Group|PHAR - Company Aggregate Debts|Debts to Book Capitalization Pharming Group N.V.|PHAR - Company Long-Term Debt|Company Short-Term Loans and Borrowings Pharming Group|Quick Liquidity Indicator pharming.com
- earnings and market ratios statistics:
PHAR - Net Profit|Company Profit Forecast Pharming Group N.V.|PHAR - Price to Earnings Ratio|Price to Future Earnings Ratio Pharming Group N.V.|PHAR - PEG Multiple|Enterprise Value to EBITDA Multiple Pharming Group NV|PHAR - Operating profit before deduction of amortization|Earnings per share for the trailing year Pharming Group|PHAR - Net earnings per share (EPS TTM)|Net earnings per share growth for the trailing year pharming.com|PHAR - Earnings per share growth in current year|Expected earnings per share trend next year Pharming Group N.V.
- sales volume and revenue information:
Fundamental valuation:Pharming Group N.V.
To select high-quality assets, an investor must confirm business sustainability through the dynamics of net profit per ordinary share. This metric measures the percentage deviation of the current EPS from the previous year's value, which in the case of Pharming Group N.V. (PHAR) allows for an assessment of the scaling efficiency of the drug Joenja by analyzing the volatility of annual earnings per share to verify real revenue growth.
Main competitors
Net earnings per share growth this year argenx SE|Net earnings per share growth this year BNTX|Earnings growth in current year Abivax SA|Earnings per share growth in current year ADMA Bio (ADMA)|Protagonist - Earnings per share growth this year|Earnings growth in current year IMVT (immunovant.com)|Kiniksa Corp (KNSA) - Earnings per share growth rate in current year|Grifols Biemat - Earnings growth in current year|ADPT - Earnings growth in current year|CLDX: Earnings growth in current year|Aurinia Pharmaceuticals Inc (AUPH) - Earnings growth in current year|Earnings per share growth in current year biocryst.com|VERA: Earnings per share increase in current year|Earnings per share growth in current year Dianthus Therapeutics, Inc. (DNTH)|PHVS (Pharvaris) - Earnings per share increase in current year|Earnings per share growth in current year AbCellera ABCL|TRML - Net earnings per share growth this year|Precigen Inc - Earnings growth in current year|Earnings per share increase in current year NKTR (Nektar Therapeutics)|upstreambio.com (UPB) - Earnings per share growth in current year|ZBIO (Zenas Biopharma Inc) - Earnings per share growth in current year|IMNM (Immunome Bio) - Earnings growth in current year|GOSS: Earnings per share increase in current year|Net earnings per share growth this year KALV (KalVista Pharmaceuticals Inc)|SEPN (Septerna Corp) - Earnings per share increase in current year|Earnings growth in current year PVLA (Pieris Corp)|SVRA - Net earnings per share growth this year|RIGL - Earnings per share growth in current year|Earnings per share increase in current year ANAB (AnaptysBio)|ATXS: Earnings growth in current year|ENGN - Expected net earnings per share growth this year|Net earnings per share growth this year RAPT|JBIO: Earnings per share increase in current year|Earnings per share growth in current year Aclaris Therapeutics (ACRS)|KYTX: Earnings per share trend in current year|Earnings growth in current year TLSA (Tiziana Life Sciences, Ltd.)|Expected net earnings per share growth this year Cabaletta Bio Inc (CABA)|ventyxbio.com - Earnings growth in current year|Earnings per share growth rate in current year theratech.com|AVTX: Earnings growth in current year|ELDN: Net earnings per one share growth for the current year|AGEN (Agenus, Inc) - Earnings growth in current year|Climb Bio, Inc. - Earnings per share trend in current year|Earnings per share growth in current year Zura Bio (ZURA)|ATYR - Earnings per share growth rate in current year|Earnings per share growth in current year Adagene ADAG|Earnings per share increase in current year IMA|STTK: Net earnings per share growth this year|Earnings per share increase in current year EQ (equilliumbio.com)|Connect Biopharma Holdings Limited (CNTB) - Earnings per share growth in current year|Immunic, Inc. (IMUX) - Earnings growth in current year|Net earnings per share growth this year ATRA|IFRX: Earnings per share increase in current year|X4 Pharmaceuticals Inc. (XFOR) - Earnings per share increase in current year|Net earnings per share growth this year Adicet ACET|Earnings growth in current year CELU (Celularity Inc)|Earnings growth in current year INmune Bio INMB|Barinthus Biotherapeutics plc - Earnings growth in current year|Kezar Life Sciences, Inc. (KZR) - Net earnings per share growth this year|SAB Biotherapeutics, Inc (SABS) - Earnings per share growth in current year|Net earnings per share growth this year Akari Therapeutics plc|Earnings per share growth in current year enlivex.com|Earnings per share growth rate in current year q32bio.com QTTB|Earnings per share growth in current year GeoVax Labs (GOVX)|EDSA (Edesa Biotech) - Earnings per share increase in current year|Earnings per share growth in current year ibioinc.com IBIO|Earnings growth in current year carismatx.com CARM|XTLB - Earnings per share growth in current year|Earnings per share increase in current year BOLT (boltbio.com)|HCW Biologics Inc (HCWB) - Earnings per share growth in current year|Net earnings per share growth this year Aptevo|Net earnings per share growth this year AIM|Earnings per share growth this year ADTX (aditxt.com)|Earnings per share growth in current year GRI Bio Inc (GRI)|XRTX (XORTX Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year HIND (Vyome Therapeutics)|REVB - Net earnings per share growth this year|INDP: Net earnings per share growth this year|Earnings per share increase in current year SCNI (Scinai)|CALI: Earnings growth in current year|Affimed NV - Earnings per share increase in current year|ALLK (Allakos) - Earnings growth in current year|Earnings per share growth rate in current year hookipapharma.com HOOK|Earnings growth in current year IGMS|ITOS - Earnings per share growth rate in current year|Earnings growth in current year OCEA (oceanbiomedical.com)|Net earnings per one share growth for the current year TCBP (TC Biopharm)|THRD: Net earnings per share growth this year
